TABLE 13.
PROPORTION OF PATIENTS WITH VISUAL ACUITY 20/40 OR BETTER, BY TUMOR LOCATION (SMALL/MEDIUM TUMORS)
| TIME POST TX | 12 MONTHS | 24 MONTHS | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Tumor Location |
RBZ + PBI (%) |
PBI (%) |
P^ |
RBZ + PBI (%) |
PBI (%) |
P^ |
| ≤ 2DD from both optic disc and fovea | 9/11 (81.8) | 27/48 (56.2) | .11 | 9/11 (81.8) | 13/37 (35.1) | .008 |
| ≤ 2DD from fovea and > 2DD from optic disc | 6/8 (75.0) | 13/16 (81.3) | .56 | 7/8 (87.5) | 9/14 (64.3) | .26 |
| ≤ 2DD from optic disc and > 2DD from fovea | 5/5 (100) | 12/15 (80) | .40 | 5/5 (100) | 7/11 (63.6) | .18 |
^
Fisher’s exact test
Tx:treatment; RBZ: ranibizumab; PBI: proton beam irradiation